| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.816 | 0.005 | 0.816 | Analgesic | 0.506 0.048 DBMET03541 0.301 0.141 DBMET03542 0.485 0.054 DBMET03543 0.419 0.077 DBMET03544 | ||
| 0.718 | 0.004 | 0.718 | Non-steroidal antiinflammatory agent | 0.195 0.075 DBMET03541 0.276 0.034 DBMET03543 0.252 0.042 DBMET03544 | ||
| 0.627 | 0.006 | 0.627 | Anticonvulsant | 0.146 0.134 DBMET03541 0.173 0.104 DBMET03543 | ||
| 0.652 | 0.04 | 0.652 | Antiinflammatory | 0.468 0.102 DBMET03541 0.356 0.168 DBMET03542 0.295 0.22 DBMET03544 | ||
| 0.591 | 0.014 | 0.591 | Spasmolytic | 0.161 0.153 DBMET03542 | ||
| 0.368 | 0.018 | 0.368 | Dual specificity phosphatase 3 inhibitor | |||
| 0.372 | 0.027 | 0.372 | Sodium/bile acid cotransporter inhibitor | |||
| 0.329 | 0.012 | 0.329 | Amyloid beta precursor protein antagonist | 0.245 0.035 DBMET03541 0.129 0.128 DBMET03543 | ||
| 0.394 | 0.08 | 0.415 | Antibacterial | 0.239 0.188 DBMET03541 0.415 0.07 DBMET03542 0.297 0.138 DBMET03543 | DBMET03542 | |
| 0.328 | 0.024 | 0.328 | Dual specificity phosphatase inhibitor | |||
| 0.233 | 0.011 | 0.251 | Cyclooxygenase 3 inhibitor | 0.162 0.038 DBMET03541 0.19 0.022 DBMET03542 0.191 0.022 DBMET03543 0.251 0.009 DBMET03544 | DBMET03544 | |
| 0.306 | 0.128 | 0.402 | 15-Lipoxygenase inhibitor | 0.402 0.074 DBMET03541 0.322 0.117 DBMET03542 0.311 0.124 DBMET03543 0.328 0.113 DBMET03544 | DBMET03541 | |
| 0.212 | 0.037 | 0.212 | Cyclooxygenase inhibitor | 0.142 0.077 DBMET03541 0.124 0.094 DBMET03542 0.136 0.082 DBMET03543 0.128 0.089 DBMET03544 | ||
| 0.254 | 0.093 | 0.417 | Insulysin inhibitor | 0.38 0.026 DBMET03541 0.331 0.042 DBMET03542 0.38 0.026 DBMET03543 0.417 0.019 DBMET03544 | DBMET03544 | |
| 0.26 | 0.127 | 0.475 | Thioredoxin glutathione reductase inhibitor | 0.475 0.034 DBMET03541 0.327 0.087 DBMET03542 0.377 0.065 DBMET03543 0.473 0.034 DBMET03544 | DBMET03541 | |
| 0.202 | 0.093 | 0.202 | Angiogenesis stimulant | |||
| 0.137 | 0.03 | 0.137 | Creatine kinase inhibitor | 0.094 0.066 DBMET03541 0.132 0.033 DBMET03543 0.094 0.066 DBMET03544 | ||
| 0.12 | 0.022 | 0.12 | Carbonic anhydrase inhibitor | |||
| 0.106 | 0.019 | 0.106 | Carbonic anhydrase XII inhibitor | |||
| 0.109 | 0.027 | 0.109 | Analgesic, opioid | |||
| 0.095 | 0.021 | 0.095 | Carbonic anhydrase IX inhibitor | |||
| 0.145 | 0.084 | 0.145 | Protein-tyrosine phosphatase inhibitor | |||
| 0.131 | 0.085 | 0.133 | Cell wall synthesis inhibitor | 0.133 0.083 DBMET03542 | DBMET03542 | |
| 0.074 | 0.028 | 0.074 | Carbonic anhydrase II inhibitor | |||
| 0.175 | 0.14 | 0.175 | Hypoglycemic | |||
| 0.064 | 0.03 | 0.064 | Aldose reductase inhibitor | |||
| 0.162 | 0.128 | 0.579 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.502 0.019 DBMET03541 0.282 0.069 DBMET03542 0.579 0.012 DBMET03543 0.564 0.013 DBMET03544 | DBMET03543 | |
| 0.046 | 0.016 | 0.046 | Squalene synthetase inhibitor | |||
| 0.19 | 0.164 | 0.258 | Gastrin inhibitor | 0.258 0.071 DBMET03541 | DBMET03541 | |
| 0.244 | 0.22 | 0.244 | Cyclophilin D inhibitor | |||
| 0.038 | 0.017 | 0.038 | Purinergic P2Y2 antagonist | |||
| 0.119 | 0.117 | 0.119 | NOS3 expression enhancer | |||
| 0.066 | 0.064 | 0.066 | CDC25A inhibitor | |||
| 0.092 | 0.092 | 0.14 | GABA C receptor antagonist | 0.125 0.047 DBMET03541 0.14 0.036 DBMET03543 | DBMET03543 | |
| 0.073 | 0.097 | 0.085 | Hematopoietic | 0.083 0.065 DBMET03541 0.079 0.076 DBMET03543 0.085 0.061 DBMET03544 | DBMET03544 | |
| 0.11 | 0.142 | 0.145 | Arachidonic acid antagonist | 0.145 0.095 DBMET03543 | DBMET03543 | |
| 0.082 | 0.131 | 0.125 | Bone formation stimulant | 0.125 0.081 DBMET03541 0.108 0.097 DBMET03544 | DBMET03541 | |
| 0.007 | 0.064 | 0.012 | CD80 antagonist | 0.011 0.008 DBMET03541 0.012 0.007 DBMET03543 | DBMET03543 | |
| 0.069 | 0.165 | 0.103 | Adenylate kinase inhibitor | 0.103 0.062 DBMET03543 | DBMET03543 | |
| 0.107 | 0.205 | 0.227 | Lipocortins synthesis antagonist | 0.227 0.042 DBMET03543 | DBMET03543 | |
| 0.034 | 0.135 | 0.065 | Porphobilinogen synthase inhibitor | 0.065 0.061 DBMET03543 | DBMET03543 | |
| 0.037 | 0.151 | 0.062 | Phosphodiesterase 1A inhibitor | 0.062 0.037 DBMET03541 | DBMET03541 | |
| 0.056 | 0.17 | 0.119 | Bromodomain-containing protein 2 inhibitor | 0.119 0.024 DBMET03541 0.102 0.037 DBMET03543 0.097 0.044 DBMET03544 | DBMET03541 | |
| 0.053 | 0.168 | 0.29 | Ferrochelatase inhibitor | 0.249 0.013 DBMET03541 0.188 0.025 DBMET03542 0.29 0.008 DBMET03543 0.271 0.01 DBMET03544 | DBMET03543 | |
| 0.13 | 0.25 | 0.196 | DNA synthesis inhibitor | 0.196 0.13 DBMET03542 0.179 0.155 DBMET03543 | DBMET03542 | |
| 0.082 | 0.205 | 0.163 | Mannose-6-phosphate isomerase inhibitor | 0.136 0.078 DBMET03541 0.163 0.054 DBMET03543 | DBMET03543 | |
| 0.086 | 0.212 | 0.134 | Sphingosine 1-phosphate receptor 2 antagonist | 0.114 0.112 DBMET03543 0.134 0.067 DBMET03544 | DBMET03544 | |
| 0.053 | 0.179 | 0.086 | NADH dehydrogenase inhibitor | 0.086 0.063 DBMET03543 | DBMET03543 | |
| 0.017 | 0.152 | 0.047 | Bromodomain-containing protein 3 inhibitor | 0.047 0.038 DBMET03541 | DBMET03541 | |
| 0.146 | 0.296 | 0.61 | GABA C receptor rho-3 antagonist | 0.475 0.033 DBMET03541 0.406 0.059 DBMET03542 0.61 0.006 DBMET03543 0.444 0.044 DBMET03544 | DBMET03543 | |
| 0.033 | 0.187 | 0.097 | Corticotropin releasing factor 2 receptor antagonist | 0.093 0.009 DBMET03541 0.071 0.027 DBMET03542 0.097 0.007 DBMET03543 0.092 0.009 DBMET03544 | DBMET03543 | |
| 0.14 | 0.297 | 0.224 | Apoptosis antagonist | 0.224 0.152 DBMET03544 | DBMET03544 | |
| 0.022 | 0.179 | 0.042 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.042 0.027 DBMET03543 | DBMET03543 | |
| 0.049 | 0.218 | 0.239 | DNA polymerase I inhibitor | 0.239 0.019 DBMET03542 | DBMET03542 | |
| 0.011 | 0.18 | 0.052 | Carbonic anhydrase VB inhibitor | 0.052 0.043 DBMET03543 | DBMET03543 | |
| 0.096 | 0.311 | 0.307 | 12-Lipoxygenase inhibitor | 0.265 0.101 DBMET03541 0.307 0.076 DBMET03543 0.285 0.088 DBMET03544 | DBMET03543 | |
| 0.003 | 0.219 | 0.017 | Carbonic anhydrase VIII inhibitor | 0.017 0.011 DBMET03544 | DBMET03544 | |
| 0.003 | 0.219 | 0.017 | Carbonic anhydrase X inhibitor | 0.017 0.011 DBMET03544 | DBMET03544 | |
| 0.033 | 0.25 | 0.145 | Hepatocyte growth factor antagonist | 0.122 0.034 DBMET03541 0.145 0.024 DBMET03543 0.107 0.045 DBMET03544 | DBMET03543 | |
| 0.044 | 0.262 | 0.098 | Carbonic anhydrase III inhibitor | 0.093 0.071 DBMET03543 0.098 0.065 DBMET03544 | DBMET03544 | |
| 0.085 | 0.309 | 0.677 | Beta lactamase inhibitor | 0.478 0.079 DBMET03541 0.234 0.165 DBMET03542 0.32 0.126 DBMET03543 0.677 0.041 DBMET03544 | DBMET03544 | |
| 0.028 | 0.254 | 0.077 | Glutamate (mGluR7) antagonist | 0.077 0.031 DBMET03543 | DBMET03543 | |
| 0.13 | 0.358 | 0.309 | Interleukin 2 agonist | 0.232 0.14 DBMET03543 0.309 0.068 DBMET03544 | DBMET03544 | |
| 0.038 | 0.266 | 0.086 | Protein kinase C zeta inhibitor | 0.086 0.072 DBMET03543 | DBMET03543 | |
| 0.007 | 0.249 | 0.024 | Antibiotic Tetracycline-like | 0.024 0.003 DBMET03542 | DBMET03542 | |
| 0.051 | 0.312 | 0.161 | Peroxidase inhibitor | 0.161 0.072 DBMET03543 | DBMET03543 | |
| 0.088 | 0.353 | 0.615 | DNA polymerase beta inhibitor | 0.46 0.098 DBMET03541 0.364 0.134 DBMET03543 0.615 0.056 DBMET03544 | DBMET03544 | |
| 0.042 | 0.316 | 0.109 | Cathepsin H inhibitor | 0.103 0.101 DBMET03542 0.109 0.09 DBMET03543 | DBMET03543 | |
| 0.097 | 0.383 | 0.141 | Ca2+-transporting ATPase inhibitor | 0.141 0.069 DBMET03543 | DBMET03543 | |
| 0.06 | 0.348 | 0.238 | GABA C receptor rho-2 antagonist | 0.183 0.04 DBMET03541 0.138 0.091 DBMET03542 0.238 0.014 DBMET03543 0.154 0.068 DBMET03544 | DBMET03543 | |
| 0.044 | 0.333 | 0.199 | NADPH oxidase inhibitor | 0.134 0.067 DBMET03541 0.199 0.035 DBMET03543 0.162 0.048 DBMET03544 | DBMET03543 | |
| 0.082 | 0.377 | 0.572 | DNA directed DNA polymerase inhibitor | 0.412 0.111 DBMET03541 0.274 0.177 DBMET03542 0.346 0.14 DBMET03543 0.572 0.063 DBMET03544 | DBMET03544 | |
| 0.02 | 0.318 | 0.076 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.076 0.045 DBMET03543 | DBMET03543 | |
| 0.033 | 0.334 | 0.066 | Transcription factor RelA inhibitor | 0.066 0.039 DBMET03543 | DBMET03543 | |
| 0.042 | 0.343 | 0.107 | Carbonic anhydrase XV inhibitor | 0.107 0.059 DBMET03543 | DBMET03543 | |
| 0.068 | 0.376 | 0.549 | Thyroid hormone antagonist | 0.358 0.071 DBMET03541 0.188 0.172 DBMET03542 0.289 0.099 DBMET03543 0.549 0.025 DBMET03544 | DBMET03544 | |
| 0.162 | 0.47 | 0.485 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.485 0.041 DBMET03541 0.349 0.152 DBMET03542 0.403 0.098 DBMET03543 0.397 0.103 DBMET03544 | DBMET03541 | |
| 0.029 | 0.339 | 0.295 | Toll-Like receptor 9 antagonist | 0.295 0.014 DBMET03541 0.271 0.017 DBMET03543 0.195 0.038 DBMET03544 | DBMET03541 | |
| 0.03 | 0.347 | 0.185 | Cyclooxygenase 1 inhibitor | 0.145 0.06 DBMET03541 0.149 0.057 DBMET03542 0.185 0.041 DBMET03543 0.156 0.053 DBMET03544 | DBMET03543 | |
| 0.075 | 0.397 | 0.3 | Histone acetyltransferase inhibitor | 0.277 0.018 DBMET03541 0.206 0.061 DBMET03542 0.3 0.014 DBMET03543 0.219 0.046 DBMET03544 | DBMET03543 | |
| 0.068 | 0.389 | 0.693 | Alpha-glucosidase inhibitor | 0.527 0.073 DBMET03541 0.345 0.138 DBMET03542 0.461 0.092 DBMET03543 0.693 0.035 DBMET03544 | DBMET03544 | |
| 0.062 | 0.395 | 0.546 | Thyroid hormone beta antagonist | 0.349 0.069 DBMET03541 0.189 0.164 DBMET03542 0.277 0.1 DBMET03543 0.546 0.024 DBMET03544 | DBMET03544 | |
| 0.04 | 0.377 | 0.106 | Phosphodiesterase 6D inhibitor | 0.106 0.042 DBMET03541 | DBMET03541 | |
| 0.025 | 0.363 | 0.143 | Cystathionine beta-synthase inhibitor | 0.143 0.044 DBMET03543 | DBMET03543 | |
| 0.015 | 0.354 | 0.06 | Phosphodiesterase 7A inhibitor | 0.048 0.046 DBMET03541 0.06 0.021 DBMET03542 | DBMET03542 | |
| 0.012 | 0.354 | 0.051 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.051 0.047 DBMET03543 | DBMET03543 | |
| 0.025 | 0.367 | 0.07 | Adenosine A3 receptor antagonist | 0.07 0.058 DBMET03541 0.069 0.06 DBMET03544 | DBMET03541 | |
| 0.031 | 0.374 | 0.129 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.099 0.055 DBMET03543 0.129 0.034 DBMET03544 | DBMET03544 | |
| 0.076 | 0.424 | 0.183 | MAP-kinase-activated kinase 5 inhibitor | 0.183 0.127 DBMET03543 | DBMET03543 | |
| 0.01 | 0.359 | 0.056 | Biliverdin reductase inhibitor | 0.056 0.045 DBMET03543 | DBMET03543 | |
| 0.031 | 0.383 | 0.217 | Alpha-N-acetylglucosaminidase inhibitor | 0.114 0.084 DBMET03541 0.106 0.093 DBMET03543 0.217 0.029 DBMET03544 | DBMET03544 | |
| 0.004 | 0.358 | 0.033 | Potassium channel small-conductance Ca-activated activator | 0.033 0.02 DBMET03541 0.032 0.021 DBMET03543 | DBMET03541 | |
| 0.052 | 0.428 | 0.108 | DNA repair enzyme inhibitor | 0.108 0.101 DBMET03543 | DBMET03543 | |
| 0.122 | 0.499 | 0.453 | Calcium channel L-type activator | 0.385 0.091 DBMET03541 0.271 0.184 DBMET03542 0.453 0.049 DBMET03543 0.393 0.086 DBMET03544 | DBMET03543 | |
| 0.024 | 0.408 | 0.195 | 5 Hydroxytryptamine 3A agonist | 0.128 0.049 DBMET03541 0.091 0.087 DBMET03542 0.195 0.016 DBMET03543 0.095 0.082 DBMET03544 | DBMET03543 | |
| 0.077 | 0.462 | 0.19 | RNA-directed DNA polymerase inhibitor | 0.181 0.131 DBMET03541 0.19 0.114 DBMET03543 | DBMET03543 | |
| 0.023 | 0.413 | 0.088 | UDP-glucose 4-epimerase inhibitor | 0.088 0.077 DBMET03544 | DBMET03544 | |
| 0.044 | 0.435 | 0.089 | CC chemokine 5 receptor agonist | 0.089 0.039 DBMET03542 0.077 0.076 DBMET03544 | DBMET03542 | |
| 0.106 | 0.501 | 0.198 | 5 Hydroxytryptamine 3E antagonist | 0.174 0.123 DBMET03541 0.171 0.132 DBMET03543 0.198 0.067 DBMET03544 | DBMET03544 | |
| 0.025 | 0.421 | 0.157 | GABA C receptor rho-1 antagonist | 0.146 0.023 DBMET03541 0.157 0.019 DBMET03543 | DBMET03543 | |
| 0.033 | 0.43 | 0.115 | Acetylcholine release stimulant | 0.115 0.057 DBMET03543 | DBMET03543 | |
| 0.09 | 0.5 | 0.22 | Tyrosine 3 hydroxylase inhibitor | 0.184 0.166 DBMET03541 0.22 0.103 DBMET03543 0.186 0.164 DBMET03544 | DBMET03543 | |
| 0.081 | 0.495 | 0.266 | Calcium channel activator | 0.266 0.128 DBMET03541 0.25 0.146 DBMET03543 | DBMET03541 | |
| 0.032 | 0.463 | 0.196 | Prostaglandin dehydrogenase inhibitor | 0.182 0.17 DBMET03541 0.196 0.159 DBMET03543 | DBMET03543 | |
| 0.061 | 0.497 | 0.175 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.175 0.1 DBMET03543 0.162 0.122 DBMET03544 | DBMET03543 | |
| 0.081 | 0.524 | 0.4 | MAP kinase 1 inhibitor | 0.395 0.109 DBMET03541 0.395 0.109 DBMET03542 0.301 0.179 DBMET03543 0.4 0.106 DBMET03544 | DBMET03544 | |
| 0.008 | 0.456 | 0.056 | Acetylcholine M5 receptor antagonist | 0.056 0.048 DBMET03542 | DBMET03542 | |
| 0.007 | 0.457 | 0.071 | Benzodiazepine agonist | 0.071 0.049 DBMET03543 | DBMET03543 | |
| 0.012 | 0.464 | 0.254 | M17 leucyl aminopeptidase inhibitor | 0.174 0.043 DBMET03541 0.124 0.074 DBMET03542 0.152 0.054 DBMET03543 0.254 0.02 DBMET03544 | DBMET03544 | |
| 0.012 | 0.468 | 0.063 | Aryl hydrocarbon receptor antagonist | 0.063 0.048 DBMET03541 | DBMET03541 | |
| 0.019 | 0.476 | 0.113 | GABA C receptor agonist | 0.113 0.055 DBMET03543 | DBMET03543 | |
| 0.044 | 0.503 | 0.229 | Focal adhesion kinase 2 inhibitor | 0.229 0.049 DBMET03541 0.209 0.063 DBMET03543 0.188 0.079 DBMET03544 | DBMET03541 | |
| 0.037 | 0.5 | 0.23 | 5 Hydroxytryptamine 1E antagonist | 0.23 0.097 DBMET03541 0.177 0.157 DBMET03543 0.198 0.133 DBMET03544 | DBMET03541 | |
| 0.019 | 0.492 | 0.123 | Protein kinase (CK1) gamma 3 inhibitor | 0.123 0.122 DBMET03543 | DBMET03543 | |
| 0.032 | 0.509 | 0.08 | D-Ala-D-Ala ligase inhibitor | 0.08 0.068 DBMET03543 | DBMET03543 | |
| 0.023 | 0.506 | 0.097 | Electrolyte absorption antagonist | 0.097 0.061 DBMET03543 0.088 0.078 DBMET03544 | DBMET03543 | |
| 0.083 | 0.574 | 0.17 | Peptidyltransferase inhibitor | 0.17 0.146 DBMET03544 | DBMET03544 | |
| 0.038 | 0.534 | 0.173 | Cyclic AMP phosphodiesterase inhibitor | 0.173 0.119 DBMET03543 | DBMET03543 | |
| 0.007 | 0.514 | 0.039 | Glutamate (mGluR1a) antagonist | 0.039 0.031 DBMET03542 | DBMET03542 | |
| 0.089 | 0.601 | 0.221 | 5 Hydroxytryptamine uptake stimulant | 0.189 0.176 DBMET03541 0.221 0.116 DBMET03543 | DBMET03543 | |
| 0.01 | 0.523 | 0.036 | Adenosine uptake inhibitor | 0.036 0.019 DBMET03542 | DBMET03542 | |
| 0.013 | 0.53 | 0.057 | 5 Hydroxytryptamine 3 agonist | 0.057 0.054 DBMET03543 | DBMET03543 | |
| 0.01 | 0.548 | 0.062 | Beta 2 adrenoreceptor agonist | 0.062 0.042 DBMET03542 | DBMET03542 | |
| 0.006 | 0.547 | 0.055 | Phosphodiesterase VII inhibitor | 0.055 0.053 DBMET03542 | DBMET03542 | |
| 0.044 | 0.594 | 0.283 | Histamine release inhibitor | 0.283 0.133 DBMET03541 0.216 0.185 DBMET03543 0.245 0.159 DBMET03544 | DBMET03541 | |
| 0.037 | 0.604 | 0.494 | Transcription factor inhibitor | 0.41 0.106 DBMET03541 0.282 0.165 DBMET03542 0.286 0.162 DBMET03543 0.494 0.077 DBMET03544 | DBMET03544 | |
| 0.005 | 0.578 | 0.074 | Leucine-rich repeat kinase 2 inhibitor | 0.074 0.064 DBMET03541 | DBMET03541 | |
| 0.027 | 0.605 | 0.092 | Glutamate (mGluR7) agonist | 0.092 0.079 DBMET03544 | DBMET03544 | |
| 0.02 | 0.602 | 0.149 | Cyclin-dependent kinase 8 inhibitor | 0.132 0.101 DBMET03541 0.149 0.08 DBMET03543 0.137 0.093 DBMET03544 | DBMET03543 | |
| 0.021 | 0.604 | 0.15 | Polo-like kinase-3 inhibitor | 0.139 0.098 DBMET03541 0.15 0.084 DBMET03543 | DBMET03543 | |
| 0.06 | 0.646 | 0.31 | 5 Hydroxytryptamine release inhibitor | 0.282 0.187 DBMET03541 0.283 0.185 DBMET03543 0.31 0.154 DBMET03544 | DBMET03544 | |
| 0.038 | 0.626 | 0.128 | MAP kinase 3 inhibitor | 0.128 0.112 DBMET03541 | DBMET03541 | |
| 0.016 | 0.604 | 0.147 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.147 0.079 DBMET03543 | DBMET03543 | |
| 0.066 | 0.679 | 0.174 | Nitric-oxide synthase stimulant | 0.174 0.143 DBMET03543 | DBMET03543 | |
| 0.052 | 0.667 | 0.165 | 5 Hydroxytryptamine release stimulant | 0.165 0.16 DBMET03543 | DBMET03543 | |
| 0.01 | 0.635 | 0.106 | Falcipain 3 inhibitor | 0.106 0.065 DBMET03544 | DBMET03544 | |
| 0.013 | 0.643 | 0.123 | Heat shock protein 90 alpha antagonist | 0.123 0.122 DBMET03543 | DBMET03543 | |
| 0.011 | 0.646 | 0.087 | Myeloperoxidase inhibitor | 0.087 0.054 DBMET03543 | DBMET03543 | |
| 0.003 | 0.64 | 0.053 | Glutamate (mGluR1) antagonist | 0.053 0.046 DBMET03541 | DBMET03541 | |
| 0.015 | 0.662 | 0.235 | Streptokinase A inhibitor | 0.181 0.146 DBMET03543 0.235 0.113 DBMET03544 | DBMET03544 | |
| 0.008 | 0.66 | 0.157 | Aryl hydrocarbon receptor agonist | 0.157 0.13 DBMET03543 0.15 0.135 DBMET03544 | DBMET03543 | |
| 0.012 | 0.665 | 0.17 | Toll-Like receptor antagonist | 0.148 0.057 DBMET03541 0.17 0.043 DBMET03543 0.108 0.107 DBMET03544 | DBMET03543 | |
| 0.062 | 0.719 | 0.475 | MAP kinase kinase 6 inhibitor | 0.475 0.025 DBMET03541 0.234 0.211 DBMET03543 | DBMET03541 | |
| 0.019 | 0.678 | 0.31 | Transcription factor STAT3 inhibitor | 0.309 0.049 DBMET03541 0.175 0.171 DBMET03542 0.174 0.173 DBMET03543 0.31 0.049 DBMET03544 | DBMET03544 | |
| 0.027 | 0.69 | 0.221 | Interleukin agonist | 0.169 0.15 DBMET03543 0.221 0.102 DBMET03544 | DBMET03544 | |
| 0.006 | 0.69 | 0.053 | Neuraminidase (Influenza A) inhibitor | 0.053 0.019 DBMET03544 | DBMET03544 | |
| 0.071 | 0.76 | 0.296 | MAP kinase kinase 3 inhibitor | 0.296 0.008 DBMET03541 0.237 0.046 DBMET03543 | DBMET03541 | |
| 0.038 | 0.746 | 0.166 | Death-associated protein kinase 2 inhibitor | 0.166 0.074 DBMET03544 | DBMET03544 | |
| 0.008 | 0.723 | 0.203 | Calpain 2 inhibitor | 0.203 0.185 DBMET03544 | DBMET03544 | |
| 0.005 | 0.725 | 0.077 | Neuraminidase (influenza) inhibitor | 0.077 0.028 DBMET03544 | DBMET03544 | |
| 0.007 | 0.732 | 0.061 | Cyclin D1 inhibitor | 0.061 0.041 DBMET03542 | DBMET03542 | |
| 0.02 | 0.748 | 0.152 | 3C-like protease (Human coronavirus) inhibitor | 0.152 0.098 DBMET03544 | DBMET03544 | |
| 0.005 | 0.755 | 0.162 | LIM domain kinase 1 inhibitor | 0.162 0.086 DBMET03542 | DBMET03542 | |
| 0.015 | 0.777 | 0.277 | Transcription factor STAT inhibitor | 0.273 0.072 DBMET03541 0.277 0.069 DBMET03544 | DBMET03544 | |
| 0.004 | 0.791 | 0.078 | Neuraminidase inhibitor | 0.078 0.027 DBMET03544 | DBMET03544 | |
| 0.009 | 0.797 | 0.105 | M18 aspartyl aminopeptidase inhibitor | 0.105 0.085 DBMET03542 | DBMET03542 | |
| 0.036 | 0.908 | 0.13 | Papain-like protease (SARS coronavirus) inhibitor | 0.13 0.061 DBMET03544 | DBMET03544 | |
| 0.006 | 0.924 | 0.082 | Aggrecanase 1 inhibitor | 0.082 0.005 DBMET03542 | DBMET03542 | |
| 0.003 | 0.978 | 0.412 | Lipase inhibitor | 0.412 0.003 DBMET03543 | DBMET03543 | |
| 0.005 | 0.988 | 0.154 | Interleukin 6 antagonist | 0.154 0.083 DBMET03542 | DBMET03542 | |
| 0.004 | 0.988 | 0.168 | Bronchodilator | 0.168 0.025 DBMET03542 | DBMET03542 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |